Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 326

1.

Development of a newborn screening tool based on bivariate normal limits: using psychosine and galactocerebrosidase determination on dried blood spots to predict Krabbe disease.

Langan TJ, Orsini JJ, Jalal K, Barczykowski AL, Escolar ML, Poe MD, Biski CK, Carter RL.

Genet Med. 2018 Dec 14. doi: 10.1038/s41436-018-0371-3. [Epub ahead of print]

PMID:
30546085
2.

Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling.

Grisanti LA, Thomas TP, Carter RL, de Lucia C, Gao E, Koch WJ, Benovic JL, Tilley DG.

Theranostics. 2018 Sep 9;8(17):4664-4678. doi: 10.7150/thno.26619. eCollection 2018.

3.

Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity.

Carter RLR, Talbot K, Hur WS, Meixner SC, Van Der Gugten JG, Holmes DT, Côté HCF, Kastrup CJ, Smith TW, Lee AYY, Pryzdial ELG.

J Thromb Haemost. 2018 Nov;16(11):2276-2288. doi: 10.1111/jth.14281. Epub 2018 Oct 9.

PMID:
30176116
4.

G protein-coupled receptor kinase 2 contributes to impaired fatty acid metabolism in the failing heart.

Pfleger J, Gross P, Johnson J, Carter RL, Gao E, Tilley DG, Houser SR, Koch WJ.

J Mol Cell Cardiol. 2018 Oct;123:108-117. doi: 10.1016/j.yjmcc.2018.08.025. Epub 2018 Aug 29.

PMID:
30171848
5.

Blood coagulation dissected.

Pryzdial ELG, Lee FMH, Lin BH, Carter RLR, Tegegn TZ, Belletrutti MJ.

Transfus Apher Sci. 2018 Aug;57(4):449-457. doi: 10.1016/j.transci.2018.07.003. Epub 2018 Jul 20. Review.

PMID:
30049564
6.

Feed and Bedding.

Carter RL, Lipman NS.

In: Weichbrod RH, Thompson GAH, Norton JN, editors. Management of Animal Care and Use Programs in Research, Education, and Testing. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2018. Chapter 27.

7.

Recruitment of African American Churches to Participate in Cancer Early Detection Interventions: A Community Perspective.

Slade JL, Holt CL, Bowie J, Scheirer MA, Toussaint E, Saunders DR, Savoy A, Carter RL, Santos SL.

J Relig Health. 2018 Apr;57(2):751-761. doi: 10.1007/s10943-018-0586-2.

8.

In Vivo [18F]GE-179 Brain Signal Does Not Show NMDA-Specific Modulation with Drug Challenges in Rodents and Nonhuman Primates.

Schoenberger M, Schroeder FA, Placzek MS, Carter RL, Rosen BR, Hooker JM, Sander CY.

ACS Chem Neurosci. 2018 Feb 21;9(2):298-305. doi: 10.1021/acschemneuro.7b00327. Epub 2017 Nov 14.

9.

Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.

Fallavollita JA, Dare JD, Carter RL, Baldwa S, Canty JM Jr.

Circ Cardiovasc Imaging. 2017 Aug;10(8). pii: e006446. doi: 10.1161/CIRCIMAGING.117.006446.

10.

Impact of paroxetine on proximal β-adrenergic receptor signaling.

Guo S, Carter RL, Grisanti LA, Koch WJ, Tilley DG.

Cell Signal. 2017 Oct;38:127-133. doi: 10.1016/j.cellsig.2017.07.006. Epub 2017 Jul 12.

11.

The Role of Leadership Support in a Church-Based Cancer Education Implementation Study.

Williams RM, Tagai EK, Santos SLZ, Slade JL, Carter RL, Holt CL.

J Relig Health. 2018 Feb;57(1):146-156. doi: 10.1007/s10943-017-0427-8.

12.

Progression of kidney disease in elderly stage 3 and 4 chronic kidney disease patients.

Arora P, Jalal K, Gupta A, Carter RL, Lohr JW.

Int Urol Nephrol. 2017 Jun;49(6):1033-1040. doi: 10.1007/s11255-017-1543-9. Epub 2017 Feb 24.

PMID:
28236138
13.

Evidence for improved survival in postsymptomatic stem cell-transplanted patients with Krabbe's disease.

Langan TJ, Barcykowski AL, Dare J, Pannullo EC, Muscarella L, Carter RL.

J Neurosci Res. 2016 Nov;94(11):1189-94. doi: 10.1002/jnr.23787.

14.

Can psychosine and galactocerebrosidase activity predict early-infantile Krabbe's disease presymptomatically?

Carter RL, Wrabetz L, Jalal K, Orsini JJ, Barczykowski AL, Matern D, Langan TJ.

J Neurosci Res. 2016 Nov;94(11):1084-93. doi: 10.1002/jnr.23793.

PMID:
27638594
15.

miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington's Disease Monkey Neural Cells.

Kunkanjanawan T, Carter RL, Prucha MS, Yang J, Parnpai R, Chan AW.

PLoS One. 2016 Sep 15;11(9):e0162788. doi: 10.1371/journal.pone.0162788. eCollection 2016.

16.

Vasopressin type 1A receptor deletion enhances cardiac contractility, β-adrenergic receptor sensitivity and acute cardiac injury-induced dysfunction.

Wasilewski MA, Grisanti LA, Song J, Carter RL, Repas AA, Myers VD, Gao E, Koch WJ, Cheung JY, Feldman AM, Tilley DG.

Clin Sci (Lond). 2016 Nov 1;130(22):2017-2027. doi: 10.1042/CS20160363. Epub 2016 Sep 2.

17.

Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.

Arora P, Gupta A, Golzy M, Patel N, Carter RL, Jalal K, Lohr JW.

BMC Nephrol. 2016 Aug 3;17(1):112. doi: 10.1186/s12882-016-0325-4.

18.

Leukocyte-Expressed β2-Adrenergic Receptors Are Essential for Survival After Acute Myocardial Injury.

Grisanti LA, Gumpert AM, Traynham CJ, Gorsky JE, Repas AA, Gao E, Carter RL, Yu D, Calvert JW, García AP, Ibáñez B, Rabinowitz JE, Koch WJ, Tilley DG.

Circulation. 2016 Jul 12;134(2):153-67. doi: 10.1161/CIRCULATIONAHA.116.022304. Epub 2016 Jun 30.

19.

β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.

Carr R 3rd, Schilling J, Song J, Carter RL, Du Y, Yoo SM, Traynham CJ, Koch WJ, Cheung JY, Tilley DG, Benovic JL.

Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):E4107-16. doi: 10.1073/pnas.1606267113. Epub 2016 Jun 27.

20.

Renin-Angiotensin-Aldosterone System Blockers in Elderly Adults with Chronic Kidney Disease without Diabetes Mellitus or Proteinuria.

Arora P, Golzy M, Patel N, Quigg R, Carter RL, Lohr JW.

J Am Geriatr Soc. 2015 Dec;63(12):2478-2484. doi: 10.1111/jgs.13842.

PMID:
26691698
21.

Prevalence of various comorbidities among veterans with chronic kidney disease and its comparison with other datasets.

Patel N, Golzy M, Nainani N, Nader ND, Carter RL, Lohr JW, Arora P.

Ren Fail. 2016;38(2):204-8. doi: 10.3109/0886022X.2015.1117924. Epub 2015 Dec 16.

PMID:
26671425
22.

Mortality incidence estimation using federal death certificate and natality data with an application to Tay-Sachs disease.

Jalal K, Carter RL.

Biom J. 2015 Sep;57(5):885-96. doi: 10.1002/bimj.201400008. Epub 2015 Jun 16.

PMID:
26080753
23.

The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray.

Deliu E, Sperow M, Console-Bram L, Carter RL, Tilley DG, Kalamarides DJ, Kirby LG, Brailoiu GC, Brailoiu E, Benamar K, Abood ME.

Mol Pharmacol. 2015 Aug;88(2):265-72. doi: 10.1124/mol.115.099333. Epub 2015 May 13.

24.

Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.

Brooks SE, Carter RL, Plaxe SC, Basen-Engquist KM, Rodriguez M, Kauderer J, Walker JL, Myers TK, Drake JG, Havrilesky LJ, Van Le L, Landrum LM, Brown CL.

Gynecol Oncol. 2015 Jul;138(1):101-8. doi: 10.1016/j.ygyno.2015.04.033. Epub 2015 Apr 30.

25.

Elevated systolic blood pressure is associated with increased incidence of chronic kidney disease but not mortality in elderly veterans.

Lohr JW, Golzy M, Carter RL, Arora P.

J Am Soc Hypertens. 2015 Jan;9(1):29-37. doi: 10.1016/j.jash.2014.10.008. Epub 2014 Nov 6.

PMID:
25537459
26.

Radiosynthesis and ex vivo evaluation of [(18)F]-(S)-3-(6-(3-fluoropropoxy)benzo[d]isoxazol-3-yl)-5-(methoxymethyl)oxazolidin-2-one for imaging MAO-B with PET.

Hicks JW, Sadovski O, Parkes J, Houle S, Hay BA, Carter RL, Wilson AA, Vasdev N.

Bioorg Med Chem Lett. 2015 Jan 15;25(2):288-91. doi: 10.1016/j.bmcl.2014.11.048. Epub 2014 Nov 24.

PMID:
25488845
27.

Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.

Grisanti LA, Repas AA, Talarico JA, Gold JI, Carter RL, Koch WJ, Tilley DG.

Am J Physiol Heart Circ Physiol. 2015 Feb 15;308(4):H316-30. doi: 10.1152/ajpheart.00635.2014. Epub 2014 Dec 5.

28.

Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells.

Carter RL, Chen Y, Kunkanjanawan T, Xu Y, Moran SP, Putkhao K, Yang J, Huang AH, Parnpai R, Chan AW.

Stem Cell Reports. 2014 Oct 14;3(4):585-93. doi: 10.1016/j.stemcr.2014.07.011. Epub 2014 Sep 4.

29.

β-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling.

Tilley DG, Zhu W, Myers VD, Barr LA, Gao E, Li X, Song J, Carter RL, Makarewich CA, Yu D, Troupes CD, Grisanti LA, Coleman RC, Koch WJ, Houser SR, Cheung JY, Feldman AM.

Circulation. 2014 Nov 11;130(20):1800-11. doi: 10.1161/CIRCULATIONAHA.114.010434. Epub 2014 Sep 9.

30.

Multiple indicators, multiple causes measurement error models.

Tekwe CD, Carter RL, Cullings HM, Carroll RJ.

Stat Med. 2014 Nov 10;33(25):4469-81. doi: 10.1002/sim.6243. Epub 2014 Jun 25.

31.

β-adrenergic receptor-dependent alterations in murine cardiac transcript expression are differentially regulated by gefitinib in vivo.

Talarico JA, Carter RL, Grisanti LA, Yu JE, Repas AA, Tilley DG.

PLoS One. 2014 Jun 5;9(6):e99195. doi: 10.1371/journal.pone.0099195. eCollection 2014.

32.

Dynamic mass redistribution analysis of endogenous β-adrenergic receptor signaling in neonatal rat cardiac fibroblasts.

Carter RL, Grisanti LA, Yu JE, Repas AA, Woodall M, Ibetti J, Koch WJ, Jacobson MA, Tilley DG.

Pharmacol Res Perspect. 2014 Feb;2(1). doi: 10.1002/prp2.24.

33.

Cell-based therapies for Huntington's disease.

Chen Y, Carter RL, Cho IK, Chan AW.

Drug Discov Today. 2014 Jul;19(7):980-4. doi: 10.1016/j.drudis.2014.02.012. Epub 2014 Mar 12. Review.

34.

β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt.

Grisanti LA, Talarico JA, Carter RL, Yu JE, Repas AA, Radcliffe SW, Tang HA, Makarewich CA, Houser SR, Tilley DG.

J Mol Cell Cardiol. 2014 Jul;72:39-51. doi: 10.1016/j.yjmcc.2014.02.009. Epub 2014 Feb 22.

35.

Renal function, calcium regulation, and time to hospitalization of patients with chronic kidney disease.

Golzy M, Bessette RW, Carter RL.

BMC Nephrol. 2013 Jul 18;14:154. doi: 10.1186/1471-2369-14-154.

36.

Differential activation of cultured neonatal cardiomyocytes by plasmalemmal versus intracellular G protein-coupled receptor 55.

Yu J, Deliu E, Zhang XQ, Hoffman NE, Carter RL, Grisanti LA, Brailoiu GC, Madesh M, Cheung JY, Force T, Abood ME, Koch WJ, Tilley DG, Brailoiu E.

J Biol Chem. 2013 Aug 2;288(31):22481-92. doi: 10.1074/jbc.M113.456178. Epub 2013 Jun 27.

37.

Lifetime risk estimators in epidemiological studies of Krabbe Disease: Review and Monte Carlo comparison.

Foss AH, Duffner PK, Carter RL.

Rare Dis. 2013 May 30;1:e25212. doi: 10.4161/rdis.25212. eCollection 2013. Review.

38.

A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group study.

Carter RL, Kang L, Darcy KM, Kauderer J, Liao SY, Rodgers WH, Walker JL, Lankes HA, Dunn ST, Stanbridge EJ.

Cancer Causes Control. 2012 Dec;23(12):2013-21. doi: 10.1007/s10552-012-0081-0. Epub 2012 Oct 17.

39.

Death rates in the U.S. due to Krabbe disease and related leukodystrophy and lysosomal storage diseases.

Barczykowski AL, Foss AH, Duffner PK, Yan L, Carter RL.

Am J Med Genet A. 2012 Nov;158A(11):2835-42. doi: 10.1002/ajmg.a.35624. Epub 2012 Sep 18.

PMID:
22991292
40.

Does orthopaedic surgical training induce hypertension? A pilot study.

Gupta HO, Gupta S, Carter RL, Mohammed A, Meek RM.

Clin Orthop Relat Res. 2012 Nov;470(11):3253-60. doi: 10.1007/s11999-012-2491-4. Epub 2012 Jul 19.

41.

Pluripotent stem cells models for Huntington's disease: prospects and challenges.

Carter RL, Chan AW.

J Genet Genomics. 2012 Jun 20;39(6):253-9. doi: 10.1016/j.jgg.2012.04.006. Epub 2012 May 9. Review.

42.

Identification of eRF1 residues that play critical and complementary roles in stop codon recognition.

Conard SE, Buckley J, Dang M, Bedwell GJ, Carter RL, Khass M, Bedwell DM.

RNA. 2012 Jun;18(6):1210-21. doi: 10.1261/rna.031997.111. Epub 2012 Apr 27.

43.

Intraoperative fluorescence imaging of peripheral and central nerves through a myelin-selective contrast agent.

Cotero VE, Siclovan T, Zhang R, Carter RL, Bajaj A, LaPlante NE, Kim E, Gray D, Staudinger VP, Yazdanfar S, Tan Hehir CA.

Mol Imaging Biol. 2012 Dec;14(6):708-17. doi: 10.1007/s11307-012-0555-1.

44.

Predicting hospital cost in CKD patients through blood chemistry values.

Bessette RW, Carter RL.

BMC Nephrol. 2011 Dec 1;12:65. doi: 10.1186/1471-2369-12-65.

45.

Relating illness complexity to reimbursement in CKD patients.

Bessette RW, Carter RL.

Int J Nephrol Renovasc Dis. 2011;4:121-30. doi: 10.2147/IJNRD.S24361. Epub 2011 Sep 19.

46.

Early infantile Krabbe disease: results of the World-Wide Krabbe Registry.

Duffner PK, Barczykowski A, Jalal K, Yan L, Kay DM, Carter RL.

Pediatr Neurol. 2011 Sep;45(3):141-8. doi: 10.1016/j.pediatrneurol.2011.05.007.

PMID:
21824559
47.

Music and video as distractors for boys with ADHD in the classroom: comparison with controls, individual differences, and medication effects.

Pelham WE Jr, Waschbusch DA, Hoza B, Gnagy EM, Greiner AR, Sams SE, Vallano G, Majumdar A, Carter RL.

J Abnorm Child Psychol. 2011 Nov;39(8):1085-98. doi: 10.1007/s10802-011-9529-z.

PMID:
21695447
48.

Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor.

Carter RL, Fricks IP, Barrett MO, Burianek LE, Zhou Y, Ko H, Das A, Jacobson KA, Lazarowski ER, Harden TK.

Mol Pharmacol. 2009 Dec;76(6):1341-8. doi: 10.1124/mol.109.058578. Epub 2009 Sep 16.

49.

Enhanced potency of nucleotide-dendrimer conjugates as agonists of the P2Y14 receptor: multivalent effect in G protein-coupled receptor recognition.

Das A, Zhou Y, Ivanov AA, Carter RL, Harden TK, Jacobson KA.

Bioconjug Chem. 2009 Aug 19;20(8):1650-9. doi: 10.1021/bc900206g. Epub 2009 Jul 2.

50.

Molecular recognition in the P2Y(14) receptor: Probing the structurally permissive terminal sugar moiety of uridine-5'-diphosphoglucose.

Ko H, Das A, Carter RL, Fricks IP, Zhou Y, Ivanov AA, Melman A, Joshi BV, Kovác P, Hajduch J, Kirk KL, Harden TK, Jacobson KA.

Bioorg Med Chem. 2009 Jul 15;17(14):5298-311. doi: 10.1016/j.bmc.2009.05.024. Epub 2009 May 15.

Supplemental Content

Loading ...
Support Center